Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults. Tandler C, Heitmann JS, Michel TM, Marconato M, et al. Int J Infect Dis 2023 Nov 26:S1201-9712(23)00770.

Read + Share

Amedeo Smart

Independent Medical Education

Tandler C, Heitmann JS, Michel TM, Marconato M, et al. Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults. Int J Infect Dis 2023 Nov 26:S1201-9712(23)00770.
PMID: 38016500